Lead Product(s) : Docosanol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Alembic Pharmaceuticals Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Abreva® (Docosanol cream 10%) in a 2 gm tube and pump formats,is used to treat "cold sores/fever blisters" (herpes labialis). It can speed up healing of the sores and decrease symptoms.
Product Name : Abreva
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 24, 2022
Lead Product(s) : Docosanol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Alembic Pharmaceuticals Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Docosanol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aleor Dermaceuticals Receives Final USFDA Approval for Cold Sore Drug
Details : Docosanol is a drug used for topical treatment for recurrent herpes simplex labialis episodes, inhibits fusion between plasma membrane and herpes simplex virus envelope, thereby preventing viral entry into cells and subsequent viral replication.
Product Name : Docosanol-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 05, 2022
Lead Product(s) : Docosanol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
